Concepedia

Stephen Hyatt

SH

Statistics

Publications

3

Citations

281

H-Index

3

Active since

2002

Affiliations

Research Triangle Park Foundation(Current)

GlaxoSmithKline (United States)

Stephen Hyatt is an author at Research Triangle Park Foundation specializing in drug development, molecular biology, and drug discovery.

Top concepts

Publications per year

2002–2010

3

Publications

3

N-(Piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A) Interaction with LYS 3.28(192) Is Crucial for Its Inverse Agonism at the Cannabinoid CB1 Receptor

Dow P. Hurst, Diane L. Lynch, Judy Barnett‐Norris et al. · Molecular Pharmacology · 2002 · 159 citations

Discovery of Tertiary Sulfonamides as Potent Liver X Receptor Antagonists

William J. Zuercher, Richard G. Buckholz, Nino Campobasso et al. · Journal of Medicinal Chemistry · 2010 · 94 citations · Full text

, , +17

On the Intractability of Estrogen-Related Receptor α as a Target for Activation by Small Molecules

Stephen Hyatt, Elizabeth L. Lockamy, Rebecca A. Stein et al. · Journal of Medicinal Chemistry · 2007 · 28 citations · Full text

1–3 of 3